ZEB1 and myeloid sarcoma: In multiple sclerosis (MS), a prototypical organ-specific autoimmune disorder, downregulation of ZEB1 effectively suppresses STAT3 phosphorylation and subsequent IL-17 expression, thereby attenuating the differentiation of pathogenic Th17 cells [16].